Resultados de la búsqueda 2211-2220 of 20232 for WHO
... who have Bacillus-Calmette-Guerin (BCG) unresponsive disease, with either carcinoma in situ with or without Ta/T1 disease. Numeración de páginas Estudios ...
... who did not have cancer. The increased risk of HF is observed as early as one year from diagnosis of cancer and overall, 7% of patients develop CHF (median ...
... who have failed 1-2 prior lines of therapy. The primary objectives are to determine the maximum tolerated dose (MTD) or highest protocol-defined dose (HPDD); ...
http://www.who.int/mediacentre/factsheets/fs327/en/#. Accessed April 4, 2022. AskMayoExpert. Chikungunya fever. Mayo Clinic; 2022. Wilson ME, et al ...
Accessed Oct. 1, 2021. Finding a living donor. UNOS Transplant Living. https://transplantliving.org/kidney/who-are-living-donors/. Accessed Oct. 1, 2021. Risks.
The purpose of this study is to continue to provide olaratumab to eligible patients who are currently receiving olaratumab commercially for the treatment of ...
Proton beam radiation therapy is one of the treatments for men with prostate cancer who have localized disease. The benefit of the combination with androgen ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?